TABLE 1.
Clinical baseline information of patients from TCGA and GEO.
| Characteristic | TCGA (n = 350) | GSE84437 (n = 433) | GSE26253 (n = 432) |
|---|---|---|---|
| Age (%) | |||
| <=65 | 6 | 283 | NA |
| >65 | 344 | 150 | NA |
| Sex (%) | |||
| Female | 124 | 137 | NA |
| Male | 226 | 296 | NA |
| Race (%) | |||
| Asian | 72 | NA | NA |
| Black | 10 | NA | NA |
| White | 222 | NA | NA |
| Other | 46 | NA | NA |
| Tumor_grade (%) | |||
| G1 | 9 | NA | NA |
| G2 | 125 | NA | NA |
| G3 | 207 | NA | NA |
| G4 | 9 | NA | NA |
| Pathologic_stage (%) | |||
| T1 | 16 | NA | 68 |
| T2 | 74 | NA | 167 |
| T3 | 161 | NA | 130 |
| T4 | 95 | NA | 67 |
| Stage_T (%) | |||
| T1 | 16 | 11 | NA |
| T2 | 74 | 38 | NA |
| T3 | 161 | 92 | NA |
| T4 | 95 | 292 | NA |
| TX | 4 | 0 | NA |
| Stage_M (%) | |||
| M0 | 312 | NA | NA |
| M1 | 23 | NA | NA |
| MX | 15 | NA | NA |
| Stage_N (%) | |||
| N0 | 103 | 80 | NA |
| N1 | 93 | 188 | NA |
| N2 | 72 | 132 | NA |
| N3 | 71 | 33 | NA |
| NX | 11 | 0 | NA |
| Status (%) | |||
| Alive | 204 | 224 | 255 |
| Dead | 146 | 209 | 177 |